Treace Medical Concepts, Inc. (TMCI) stock
TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3031% below fair value
$4.53+0.09 (+2.03%)
Close on Nov 18, 2026Market cap $294.61MP/E –Yield –
Treace Medical Concepts operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Treace Medical Concepts's operating income for the twelve months ending Jun 30, 2026 was -$53.72M. For fiscal 2025 it was -$54.15M. The highest annual figure on record is $855.00K in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$54.15M | – |
| FY2024 | Dec 31, 2024 | -$55.69M | – |
| FY2023 | Dec 31, 2023 | -$51.43M | – |
| FY2022 | Dec 31, 2022 | -$34.84M | – |
| FY2021 | Dec 31, 2021 | -$16.51M | -2031.0% |
| FY2020 | Dec 31, 2020 | $855.00K | – |
| FY2019 | Dec 31, 2019 | -$3.54M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$14.96M | – |
| Q1 FY2026 | Mar 31, 2026 | -$17.17M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.92M | – |
| Q3 FY2025 | Sep 30, 2025 | -$15.68M | – |
| Q2 FY2025 | Jun 30, 2025 | -$16.97M | – |
| Q1 FY2025 | Mar 31, 2025 | -$15.58M | – |
| Q4 FY2024 | Dec 31, 2024 | -$204.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$15.13M | – |
| Q2 FY2024 | Jun 30, 2024 | -$21.38M | – |
| Q1 FY2024 | Mar 31, 2024 | -$18.97M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.78M | – |
| Q3 FY2023 | Sep 30, 2023 | -$17.82M | – |
| Q2 FY2023 | Jun 30, 2023 | -$13.05M | – |
| Q1 FY2023 | Mar 31, 2023 | -$13.78M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.50M | – |
| Q3 FY2022 | Sep 30, 2022 | -$11.32M | – |
| Q2 FY2022 | Jun 30, 2022 | -$11.93M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.10M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.60M | -254.0% |
| Q3 FY2021 | Sep 30, 2021 | -$5.46M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.05M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.40M | – |
| Q4 FY2020 | Dec 31, 2020 | $3.64M | – |
| Q3 FY2020 | Sep 30, 2020 | -$63.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.52M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.20M | – |
See a number that looks wrong?